ADGM (Adagio Medical Holdings) EBITDA Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Adagio Medical Holdings's EBITDA for the three months ended in Dec. 2024 was $0.00 Mil. Adagio Medical Holdings's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Adagio Medical Holdings's EBITDA margin for the quarter that ended in Dec. 2024 was 0.00%.

Adagio Medical Holdings EBITDA Margin % Historical Data

The historical data trend for Adagio Medical Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings EBITDA Margin % Chart

Adagio Medical Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

-7,260.00

-12,191.01

-11,985.00

Adagio Medical Holdings Quarterly Data
	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial			-25,063.41	-12,137.18	-26,669.23	-	-

Competitive Comparison of Adagio Medical Holdings's EBITDA Margin %

For the Medical Devices subindustry, Adagio Medical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adagio Medical Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Adagio Medical Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Adagio Medical Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	%

Adagio Medical Holdings's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Adagio Medical Holdings (NAS:ADGM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Adagio Medical Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagio Medical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653

Website

https://www.adagiomedical.com

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.